GLP-1 receptor agonists, CKD, and eGFR trajectory replyKatherine R. Tuttle,Mark C. Lakshmanan,Brian Rayner,Robert S. Busch,Alan G. Zimmermann,D. Bradley Woodward,Fady T. BotrosThe Lancet Diabetes & Endocrinology(2018)引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要